×

Cookie Settings

We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operations of the website, as well as cookies that are only used for anonymous statistical purposes, for comfort settings or to display personalized content. Please note that based on your settings, it is possible that not all functionalities of the website will be available. You can find further information in our privacy policy.

Please make your personal preference here:

Imprint

 
 
Shopping Cart - CHF 0.00

You have no items in your shopping cart.

  • Home  » 
  • 4030778
Return to Previous Page
4030778

Availability: In stock

rec IGF-I (human)

4030778

Product No. Pack Size Available ADS InfoAnalytical Data Sheet List Price Online Order Price Qty
4030778.0100 100 µg Ships within 1 business day ADSExemplary Data Sheet of a current available lot.
CHF 305.00
CHF 283.65 (7%)
4030778.0500 0.5 mg Ships within 3-5 business days  
CHF 1,220.00
CHF 1,134.60 (7%)

Details

approx. ED₅₀ = 0.8 ng/mL IGF-I regulates the proliferation and differentiation of a multitude of cell types, and also exhibits insulin-like effects, which are, in the case of glucose metabolism, opposite to those of the growth hormone (GH). IGF 'replacement' in diabetes is under investigation and new methods of delivering IGF-I as a complex offer exciting new prospects.
Catalog Number H-5555
Synonyms Somatomedin C
CAS Registry Number 67763-96-6
Source Recombinant
Storage Conditions -20 ± 5 °C
Keywords Recombinant protein
Application Cell Culture
Diabetes
Links / Documents:
Brochures:

Bachem product citations

K.Higuchi et al., Gen. Comp. Endocrinol., 232, 86 (2016)
L.Cruz-Garcia et al., Domest. Anim. Endocrinol., 51, 86 (2015)
R.Dobie et al., J. Cell. Physiol., 230, 2796 (2015)
C.Salmeron et al., Domest. Anim. Endocrinol., 45, 1 (2013)
V.Jimenez-Amilburu et al., Gen. Comp. Endocrinol., 188, 151 (2013)
C.Pass et al., J. Bone Miner. Res., 27, 1055 (2012)
E.Capilla et al., Gen. Comp. Endocrinol., 172, 107 (2011)
M.Hie et al., Int. J. Mol. Med., 28, 455 (2011)
M.Rius-Francino et al., Gen. Comp. Endocrinol., 172, 44 (2011)
S.Blumenthal et al., Am. J. Physiol. Endocrinol. Metab., 301, E628 (2011)
S.M.de la Monte et al., Hepatol. Res., 41, 386 (2011)
S.M.Denucci et al., Gastroenterol. Res. Pract., 2010, (2010)
L.Bouraoui et al, Am. J. Physiol. Regul. Integr. Comp. Physiol., 299, R33 (2010)
M.S.Kim et al., Biochem. Biophys. Res. Commun., 385, 38 (2009)
S.M.de la Monte et al., Mol. Neurodegener., 4, 54 (2009)
S.M.de la Monte et al., Alcohol. Clin. Exp. Res., 32, 1630 (2008)
V.E.Macrae et al., Growth Horm. IGF Res., 17, 435 (2007)
C.H.Gravholt et al., Growth Horm. IGF Res., 16, 332 (2006)
S.E.Echternkamp et al., J. Anim. Sci., 84, 2057 (2006)
B.A.Hoshaw et al., Brain Res., 1037, 204 (2005)
C.Montessuit et al., Cardiovasc. Res., 64, 94 (2004)
F.Andre et al., Oncogene, 23, 1177 (2004)
V.S.Bonert et al., J. Clin. Endocrinol. Metab., 89, 3397 (2004)
D.Hallmann et al., J. Biol. Chem., 278, 5099 (2003)
P.B.Johansen et al., Exp. Diabesity Res., 4, 73 (2003)
F.F.Lauszus et al., Obstet. Gynecol., 97, 734 (2001)
G.Iniguez et al., Reproduction, 122, 865 (2001)
H.Hallak et al., J. Neurochem., 77, 63 (2001)
P.Lohrer et al., Neuroendocrinology, 74, 95 (2001)
T.Mine et al., Osaka City Med. J., 46, 129 (2000)
M.Lesort et al., J. Neurochem., 72, 576 (1999)
C.De Felipe and S.P.Hunt, J. Neurosci., 14, 2911 (1994)

Product citations

R.I.G.Holt et al., Diabet. Med., 20, 3 (2003)
W.S.Cohick and D.R.Clemmons, Annu. Rev. Physiol., 55, 131 (1993)
A.M.Cotterill, Clin. Endocrinol., 37, 11 (1992)
R.King et al., J. Mol. Endocrinol., 8, 29 (1992)
R.E.Humbel, Eur. J. Biochem., 190, 445 (1990)
E.Rinderknecht and R.E.Humbel, J. Biol. Chem., 253, 2769 (1978)